Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDReata Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/07/2023 | Q2 2023 | $2.88 | $5.12 | 2.24 | N/A | $22.75 M |
| 05/10/2023 | Q1 2023 | $2.34 | -$3.00 | -5.34 | N/A | $195.00 K |
| 02/24/2023 | Q4 2022 | -$2.21 | -$2.35 | -0.14 | N/A | $914.00 K |
| 11/08/2022 | Q3 2022 | $2.35 | -$2.10 | -4.45 | N/A | $540.00 K |
| 08/08/2022 | Q2 2022 | $1.90 | -$2.02 | -3.92 | N/A | $762.00 K |
| 05/10/2022 | Q1 2022 | $2.26 | -$2.03 | -4.29 | N/A | $914.00 K |
| 02/28/2022 | Q4 2021 | $2.31 | -$2.35 | -4.66 | N/A | $934.00 K |
| 11/08/2021 | Q3 2021 | $2.32 | -$1.97 | -4.29 | N/A | $7.39 M |
| 08/09/2021 | Q2 2021 | $2.13 | -$2.00 | -4.13 | N/A | $2.22 M |
| 05/06/2021 | Q1 2021 | $2.18 | -$1.86 | -4.04 | N/A | $944.00 K |
| 03/01/2021 | Q4 2020 | $2.14 | -$1.90 | -4.04 | N/A | $3.19 M |
| 11/09/2020 | Q3 2020 | $2.10 | -$1.94 | -4.04 | N/A | $1.40 M |
| 08/10/2020 | Q2 2020 | $2.22 | -$2.03 | -4.25 | N/A | $3.07 M |
| 05/11/2020 | Q1 2020 | $1.97 | -$1.47 | -3.44 | N/A | $1.35 M |
| 02/19/2020 | Q4 2019 | $6.15 | -$5.91 | -12.06 | N/A | $2.67 M |
| 11/12/2019 | Q3 2019 | $1.25 | -$1.32 | -2.57 | N/A | $8.24 M |
| 08/08/2019 | Q2 2019 | $1.12 | -$1.14 | -2.26 | N/A | $7.83 M |
| 05/09/2019 | Q1 2019 | $0.97 | -$0.98 | -1.95 | N/A | $7.77 M |
| 02/28/2019 | Q4 2018 | $1.02 | -$0.86 | -1.88 | N/A | $8.45 M |
| 11/07/2018 | Q3 2018 | $0.82 | -$1.07 | -1.89 | N/A | $5.18 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Reata Pharmaceuticals, Inc. Earnings: FAQ's
Reata Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 5th, 2023 based offlast year's report dates.
The conference call for Reata Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Reata Pharmaceuticals, Inc.'s latest earnings report can be read online.
Reata Pharmaceuticals, Inc. (:RETA) has a recorded annual revenue of $2.22 M.
Reata Pharmaceuticals, Inc. (:RETA) has a recorded net income of $-311,901,000.Reata Pharmaceuticals, Inc. has generated $-8.59 earnings per share over the last four quarters.
Reata Pharmaceuticals, Inc. (:RETA) has a price-to-earnings ratio of -20.07 and price/earnings-to-growth ratio is -0.2.